Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Plos One|February 25, 2012
A novel classification of lung cancer into molecular subtypesLisandra West, Smruti J Vidwans, Nicholas P Campbell, et al.
Oncotarget|March 25, 2014
Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancerShigeru Kawabata, Chun-Te Chiang, Junji Tsurutani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2019
Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC StudyAnne-Marie Boothman, Marietta Scott, Marianne Ratcliffe, et al.
Molecular Cancer Therapeutics|May 10, 2011
Expression signatures of the lipid-based Akt inhibitors phosphatidylinositol ether lipid analogues in NSCLC cellsChunyu Zhang, Abdel G Elkahloun, Hongling Liao, et al.
The Journal of Experimental Medicine|October 29, 2003
Immune evasion by murine melanoma mediated through CC chemokine receptor-10Takashi Murakami, Adela R Cardones, Steven E Finkelstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumorsCourtney A Granville, Noel Warfel, Junji Tsurutani, et al.
Pageof 9